Investors Are Craving More from NeuroMetrix Inc. [NURO] Stocks: Here is Why

NeuroMetrix Inc. [NURO] has traded in a range of $0.81 to $6.20 in the last 1 year. As of this writing, the stock is at $2.15, up 9.14%. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. Over the last week, NURO shares are 3.86% up with the monthly amount drift of 37.82% and seems well in a long time frame.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


On 22, October 2020, NeuroMetrix Reports Q3 2020 Financial Results. According to news published on Yahoo Finance, NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2020. The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chronic health conditions.

Analyst Birdseye View:

The most recent analyst activity for NeuroMetrix Inc. [NASDAQ:NURO] stock was on June 28, 2016, when it was Initiated with a Buy rating from Rodman & Renshaw, which also raised its 12-month price target on the stock to $4.50. Before that, on October 20, 2017, H.C. Wainwright Recapitulated a Buy rating and elevated its amount target to $3. On September 11, 2015, Maxim Group Initiated a Buy rating and boosted its price target on this stock to $2. On February 27, 2012, Dawson James Initiated a Buy rating and increased its price target to $3.

In the past 52 weeks of trading, this stock has oscillated between a low of $0.81 and a peak of $6.20. Right now, according to Wall Street analyst the average 12-month amount target is $50.00. At the most recent market close, shares of NeuroMetrix Inc. [NASDAQ:NURO] were valued at $2.15.


NeuroMetrix Inc. [NASDAQ:NURO] most recently reported quarterly sales of 2.04 billion, which represented growth of -4.80%. This publicly-traded organization’s revenue is $403,153 per employee, while its income is -$164,044 per employee. This company’s Gross Margin is currently 68.40%, its Operating Margin is -38.50%, its Pretax Margin is -40.69, and its Net Margin is -40.69. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -39.70, -87.46, -168.04 and -79.06 respectively.

The Principal structure of this organization shows its whole liability to whole principal at 37.30 and the whole liability to whole assets at 21.83. It shows enduring liability to the whole principal at 22.72 and enduring liability to assets at 0.13 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 2.04 points at 1st support level, the second support level is making up to 1.93. But as of 1st resistance point, this stock is sitting at 2.22 and at 2.29 for 2nd resistance point.

NeuroMetrix Inc. [NURO] reported its earnings at -$3 per share in the fiscal quarter closing of 12/30/2019. The Analysts for Wall Street were expecting to report its earnings at -$1.8/share signifying the difference of -1.2 and -66.70% surprise value. Comparing the previous quarter ending of 9/29/2019, the stated earnings were -$1.4 calling estimates for -$1.5/share with the difference of 0.1 depicting the surprise of 6.70%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for NeuroMetrix Inc. [NASDAQ:NURO] is 3.10. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.91. Now if looking for a valuation of this stock’s amount to sales ratio it’s 0.45 and it’s amount to book ratio is 2.38.

Insider Stories

The most recent insider trade was by Gozani Shai, President & CEO, and it was the purchase of 1000.0 shares on Jun 11. Gozani Shai, the President & CEO, completed a purchase of 500.0 shares on May 21. On May 14, Gozani Shai, President & CEO, completed a purchase of 1000.0 shares.